ID: ALA3828080

Max Phase: Preclinical

Molecular Formula: C20H14O3

Molecular Weight: 302.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccccc1C(=O)c1ccc2c3c(cccc13)CC2

Standard InChI:  InChI=1S/C20H14O3/c21-19(15-5-1-2-6-17(15)20(22)23)16-11-10-13-9-8-12-4-3-7-14(16)18(12)13/h1-7,10-11H,8-9H2,(H,22,23)

Standard InChI Key:  ZEWLGPFHBSBEEG-UHFFFAOYSA-N

Associated Targets(non-human)

Botulinum neurotoxin type E 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 302.33Molecular Weight (Monoisotopic): 302.0943AlogP: 3.87#Rotatable Bonds: 3
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.45CX Basic pKa: CX LogP: 4.64CX LogD: 1.25
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -0.24

References

1. Kumar G, Agarwal R, Swaminathan S..  (2016)  Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model.,  24  (18): [PMID:27353886] [10.1016/j.bmc.2016.06.036]

Source